Neuropsychological, neuropsychiatric, and quality‐of‐life assessments in Alzheimer's disease patients treated with plasma exchange with albumin replacement from the randomized AMBAR study-Reference-Cited by-同舟云学术

Neuropsychological, neuropsychiatric, and quality‐of‐life assessments in Alzheimer's disease patients treated with plasma exchange with albumin replacement from the randomized AMBAR study

Published:2021-11-02 Issue: Volume: Page:
ISSN:1552-5260
Container-title:Alzheimer's & Dementia
language:en
Short-container-title:Alzheimer's & Dementia

Author:

Boada Mercè¹²,López Oscar L.³,Olazarán Javier⁴⁵,Núñez Laura⁶,Pfeffer Michael⁷,Puente Orlando⁸,Piñol‐Ripoll Gerard⁹,Gámez José E.¹⁰,Anaya Fernando¹¹,Kiprov Dobri¹²,Alegret Montserrat¹,Grifols Carlota⁶,Barceló Miquel⁶,Bozzo Jordi⁶,Szczepiorkowski Zbigniew M.¹³¹⁴,Páez Antonio⁶^ORCID,

Affiliation:

1. Research Center and Memory Clinic Fundació ACE Institut Català de Neurociències Aplicades‐Universitat Internacional de Catalunya Barcelona Spain

2. Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas (CIBERNED) Instituto de Salud Carlos III Madrid Spain

3. Departments of Neurology and Psychiatry University of Pittsburgh School of Medicine Pittsburgh Pennsylvania USA

4. Neurology Service Hospital General Universitario Gregorio Marañón Madrid Spain

5. Memory Disorders Clinic HM Hospitales Madrid Spain

6. Alzheimer's Research Group Grifols Barcelona Spain

7. Medical Services Allied Biomedical Research Institute, Inc. Miami Florida USA

8. Center for Prevention of Alzheimer's Disease Miami Dade Medical Research Institute Miami Florida USA

9. Cognitive Disorders Unit Clinical Neuroscience Research IRB Lleida‐Hospital Universitari Santa Maria Lleida Spain

10. Psychiatry Department Galiz Research Hialeah Florida USA

11. Nephrology Service Hospital General Universitario Gregorio Marañón Madrid Spain

12. Apheresis Care Group and Fresenius Medical Care San Francisco California USA

13. Department of Pathology and Laboratory Medicine Dartmouth Hitchcock Medical Center Lebanon New Hampshire USA

14. Institute of Hematology and Transfusion Medicine Warsaw Poland

Funder

Grifols

Publisher

Wiley

Subject

Psychiatry and Mental health,Cellular and Molecular Neuroscience,Geriatrics and Gerontology,Neurology (clinical),Developmental Neuroscience,Health Policy,Epidemiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/alz.12477

Reference49 articles.

1. Genetic data and cognitively defined late‐onset Alzheimer's disease subgroups;Mukherjee S;Mol Psychiatry,2018

2. Quality of Life in Alzheimer Disease

3. Memantine Treatment in Patients With Moderate to Severe Alzheimer Disease Already Receiving Donepezil

4. A randomised placebo controlled study to assess the effects of cholinergic treatment on muscarinic receptors in Alzheimer's disease

5. Effect of Idalopirdine as Adjunct to Cholinesterase Inhibitors on Change in Cognition in Patients With Alzheimer Disease

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Low-Density Lipoprotein Receptor-Related Protein 1 as a Potential Therapeutic Target in Alzheimer’s Disease;Pharmaceutics;2024-07-17

2. Subclinical structural atypicality of retinal thickness and its association with gray matter volume in the visual cortex of maltreated children;Scientific Reports;2024-05-20

3. Downregulation of miR-181c-5p in Alzheimer’s disease weakens the response of microglia to Aβ phagocytosis;Scientific Reports;2024-05-20

4. Alzheimer’s disease: insights into pathology, molecular mechanisms, and therapy;Protein & Cell;2024-05-11

5. Understanding treatment goals and their application in clinical trial design for patients with Alzheimer disease and caregivers;Drugs in Context;2024-04-29